HeartLung.AI Concludes ESC Congress 2026 With Unprecedented 10-Study Program and Agatston-2.0 Results
Company-record scientific program shows how AI can uncover coronary, chamber, valvular, plaque and lung cancer risk insights from routine CT. MUNICH , GERMANY, September 3, 2026 /EINPresswire.com/ -- HeartLung.AI today announced the successful …